Astellas Pharma: Clinical Trials & Research Profile

Biopharma Industry (Tokyo, JP / Northbrook, IL) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Tokyo, JP / Northbrook, IL)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies28 active (15 recruiting now)
Total Tracked Studies (2018 to 2026)63 (31 with California sites)
Completed vs Early-Stopped Studies28 completed / 7 stopped (11.1% stop rate)
Median Closed Enrollment149 participants
FDA Drugs@FDA Original Approvals27 all-time (8 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Astellas Pharma across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk